4th Quarter - Report — ALKERMES, INC. for ALKERMES, INC. (2017)

Firm

ALKERMES, INC.

Client

ALKERMES, INC.

Income

—

Expenses

$1,000,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Advance the use, and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings PL#114-198 Funding and implementation of Comprehensive Addiction and Recovery Act PL 115-90 Continuing Appropriations for FY18 PL 115-96 To amend the HomeLand Security Act of 2002 Ensure availability of all treatments for addiction in the Veterans Affairs and Indian Health Services, and through the Substance Abuse & Mental Health Services Administration. Advance use of addiction medicines in the Bureau of Prisons and within criminal justice funding (Byrne Jag)

Lobbyist	Covered position, as disclosed
ROBERT FORMAN	—
MEGAN JACKSON	Deputy Chief of Staff/Legislative Director for Congressman Brett Guthrie (KY-02)
PETER NORMAN	—
ABIGAIL PINKELE	Legislative Director for Rep. Gene Green from 2003-2012

Contacted: Executive Office of the President (EOP); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA)

Health Issues HCR

Confronting the opioid and mental illness epidemic Awareness of the need for treatment system reform and access to all FDA-approved medications

Lobbyist	Covered position, as disclosed
ROBERT FORMAN	—
MEGAN JACKSON	Deputy Chief of Staff/Legislative Director for Congressman Brett Guthrie (KY-02)
PETER NORMAN	—
ABIGAIL PINKELE	Legislative Director for Rep. Gene Green from 2003-2012

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Executive Office of the President (EOP); Substance Abuse & Mental Health Services Administration (SAMHSA); Veterans Affairs, Dept of (VA); SENATE; Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Maintain six protected classes for depression and schizophrenia under Medicare Part D

Lobbyist	Covered position, as disclosed
ROBERT FORMAN	—
MEGAN JACKSON	Deputy Chief of Staff/Legislative Director for Congressman Brett Guthrie (KY-02)
PETER NORMAN	—
ABIGAIL PINKELE	Legislative Director for Rep. Gene Green from 2003-2012

Contacted: Executive Office of the President (EOP); SENATE; Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Substance Abuse & Mental Health Services Administration (SAMHSA); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Pharmacy PHA

Public law #114-198, 21st Century Cures Opioid Implementation Awareness of outcomes data and the need for training on all medication assisted treatment

Lobbyist	Covered position, as disclosed
ROBERT FORMAN	—
MEGAN JACKSON	Deputy Chief of Staff/Legislative Director for Congressman Brett Guthrie (KY-02)
PETER NORMAN	—
ABIGAIL PINKELE New	Legislative Director for Rep. Gene Green from 2003-2012

Contacted: Health & Human Services, Dept of (HHS); Substance Abuse & Mental Health Services Administration (SAMHSA); SENATE; Natl Institutes of Health (NIH); Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP); Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.